MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about JNJ

Recent news which mentions JNJ

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
32 33 Next >
Coinbase, Apple And Robinhood Are Among Top Large-Cap Losers Last Week (Mar 10-Mar 14): Are The Others In Your Portfolio?
Tickers AAPL ADBE COIN DAL
Tags why it's moving TER SAIL
From Benzinga
Allegations of Inflated Prescription Drug Costs Spark Employee Lawsuit Against JPMorgan
Tickers CVS JNJ JPM NEWS
Tags CVS Top Stories Benzinga
From Benzinga
Kroger CEO Shake-Up
Tickers ACI ANF GOOG GOOGL
Tags ACI KR Market News
From Motley Fool
Cool, Calm, and Collected: 2 Dividend ETFs to Buy During the S&P 500 Sell-Off
Tickers JNJ KO VIG VYM
Tags Recent Press Releases WMT VYM
From Motley Fool
Generate Passive Income From This Low-Cost Vanguard ETF That Is Crushing the S&P 500 in 2025
Tickers AAPL ABBV AMZN AVGO
Tags PG WMT Recent Press Releases
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Tickers ABBV BMY CI IQV
Tags BMY SYK JNJ
From Benzinga
Vanguard High Dividend Yield ETF vs Vanguard Dividend Appreciation ETF: Which Is Best for You?
Tickers AAPL ABBV AVGO BAC
Tags V BAC WMT
From Motley Fool
How Exxon Mobil, Johnson & Johnson, And Cogent Communications Can Put Cash In Your Pocket
Tickers CCOI JNJ XOM
Tags CCOI JNJ Personal Finance Access
From Benzinga
2025 March Market Cap Showdown: Andy Cross vs. Matt Argersinger
Tickers AAPL ACN AMZN AX
Tags ACN BNED ROKU
From Motley Fool
Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment
Tickers JNJ
Tags Options BZI/UOA Benzinga
From Benzinga
Why Is Protagonist Therapeutics Stock Trading Higher On Monday?
Tickers BMY JNJ NEWS PTGX
Tags Trading Ideas Benzinga why it's moving
From Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Tickers BMY CVS JNJ NEWS
Tags Pre/Market Outlook Analyst Ratings Market News
From Benzinga
Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'
Tickers ITCI JNJ NEWS NMRA
Tags News Biotech NMRA
From Benzinga
ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug
Tickers CGON IBRX JNJ MRK
Tags IBRX Analyst Ratings Market News
From Benzinga
2 Dow Stocks to Buy Hand Over Fist in March and 1 to Avoid
Tickers BA DJI JNJ UNH
Tags BA ^DJI UNH
From Motley Fool
What 14 Analyst Ratings Have To Say About Johnson & Johnson
Tickers JNJ
Tags Market News Analyst Ratings JNJ
From Benzinga
Tech Sector Hammered As Trump's Tariff Plans Spark Market Selloff: Nvidia, ARM, Super Micro Lead Tech Bloodbath
Tickers APP ARM CEG DLTR
Tags SOFI HIMS Benzinga
From Benzinga
What the Options Market Tells Us About Johnson & Johnson
Tickers JNJ
Tags Markets JNJ Market News
From Benzinga
Warren Buffett's State of the Market
Tickers AAPL BRK-A BRK-B JNJ
Tags TSM SCHW Recent Press Releases
From Motley Fool
These Vanguard ETFs Show Where the Smart Money Is Moving Now
Tickers ABBV COST EDV JNJ
Tags UNH VEA VGK
From Motley Fool
3 Top High-Yield Dividend Stocks I Plan to Buy in March for More Passive Income
Tickers JNJ PEP PLD
Tags PLD PEP Recent Press Releases
From Motley Fool
3 Dividend Stocks That Are No-Brainer Buys Right Now
Tickers JNJ NVS PFE
Tags Market News Recent Press Releases JNJ
From Motley Fool
Bitcoin, Magnificent 7 Lose Safe-Haven Status In 2025 As China ETFs, Dow Stocks Outperform
Tickers AAPL AMGN AMZN BABA
Tags Market News tariffs SPY
From Benzinga
Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang
Tickers JNJ LVTX NEWS PFE
Tags Briefs Price Target Downgrades
From Benzinga
Wall Street's Greatest Dividend Stock Just Made History Again -- and 99.9% of Investors Have Never Heard of This Small-Cap Company
Tickers JNJ KO SWK XOM
Tags KO YORW XOM
From Motley Fool
Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says
Tickers CMPS JNJ NEWS
Tags JNJ Health Care Briefs
From Benzinga
Johnson & Johnson Sues Samsung Bioepis Over Alleged Biosimilar Agreement Breach For Its Flagship Psoriasis Drug
Tickers JNJ NEWS
Tags Benzinga Expert Ideas Top Stories
From Benzinga
A Closer Look at Johnson & Johnson's Options Market Dynamics
Tickers JNJ
Tags BZI/UOA Benzinga Options
From Benzinga
2 Very Healthy High-Yield Dividend Stocks to Buy for a Safe and Growing Passive Income Stream
Tickers JNJ MDT
Tags Recent Press Releases JNJ MDT
From Motley Fool
Buy This Ultra-Safe High-Yield Dividend King Stock for Reliable Passive Income
Tickers JNJ KVUE
Tags Market News KVUE Recent Press Releases
From Motley Fool
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story